TOTufan Oge

Tufan Oge

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Tufan Oge has a total of 86 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    CCL11 rs16969415 and CCR3 rs4987053 gene variants and endometrial cancer risk

    by Emine Yağcı, Muhammed Olgen, Gamze Zengin, Cansu Özbayer, Tufan Öge, Hülyam Kurt

    Aim: Endometrial cancer is the sixth most frequent malignancy in women worldwide. Chemokines are tiny cytokines that are produced to enable different cell types to migrate in different directions. They are crucial for a number of physiological functions, including immunological responses, wound healing, and the development of cancer. Our study aimed to determine the association between CCL11 rs16969415 and CCR3 gene rs4987053 variants and the risk of endometrial cancer. Methods: Ninety healthy controls and ninety endometrial cancer patients participated in this case-control research. Blood samples were used to obtain genomic DNA, and the Polymerase Chain Reaction-Restriction Fragment Length Polymorphism (PCR-RFLP) method was used to determine genotypes. Results: The CCL11 gene rs16969415 and the CCR3 gene rs4987053 genotype distributions and allele frequencies were found to differ substantially between the patient and control groups (respectively p

  • Open Access

    Association of PTEN Gene Polymorphisms, Protein Levels and Endometrial Cancer: A Hospital-Based Case-Control Study

    by Emine Yağci, Hikmet Melike Öztürk, Tufan Öge, Cansu Ozbayer, Hülyam Kurt

    Association of PTEN Gene Polymorphisms, Protein Levels and Endometrial Cancer: A Hospital-Based Case-Control Study Emine Yagci1, Hikmet Melike Ozturk1, Tufan Oge2, Cansu Ozbayer3, Hulyam Kurt1 0000-0003-2179-1318, 0000-0002-1951-9713,0000-0002-1120-1874, 0000-0003-2433-9925 1Eskisehir Osmangazi University, Faculty of Medicine, Department of Medical Biology, Eskisehir, Turkey. 2 Eskisehir Osmangazi University, Faculty of Medicine, Department of Gynecology, Eskisehir, Turkey. 3 Kutahya Health Sciences University, Medical Faculty, Department of Medical Biology, Kutahya, Turkey. Corresponding Author: Emine Yagci, Telephone: +90 (222) 2392979/4598, e-mail adress: eminetsci@gmail.com Abstract Endometrial cancer is a type of cancer that develops in the inner lining of the uterus, called the endometrium. After breast, lung, and colon cancer, endometrial cancer is the most prevalent malignancy of the female genital system in industrialized nations like North America and Europe. Phosphatase and Tensin homolog (PTEN), deleted on chromosome 10, is a tumor suppressor gene located on chromosome 10q23.31, which encodes a 403 amino acid protein with both lipid and protein phosphatase activities. One of the most common genetic abnormalities identified in human malignancies are somatic mutations in the PTEN gene. The tumor suppressor activity of the PTEN enzyme is reduced or completely lost as a result of PTEN gene mutations. Considering this information, it is thought that PTEN gene polymorphisms may be associated with the pathogenesis of the disease. The purpose of our study is to determine the relationship between functional PTEN polymorphisms IVS4 (–/+) and -9 C/G and endometrial cancer. DNAs belonging to 63 endometrial cancer patients and 63 control individuals were genotyped by PCR-RFLP method for 2 genetic variants of PTEN IVS4 (–/+) and -9 C/G gene. The expression level of PTEN protein was measured by the Elisa method from serum samples. Our results were evaluated with appropriate statistical methods. As a result of our study, no statistically significant difference was found in the risk of endometrial cancer and genotype frequencies of –9 C/G and IVS4 (-/+) variants (p> 0.05). It was detected that the serum level of PTEN lessened significantly in patients with endometrial cancer in comparison to the control (p


  • Open Access

    Ultrasonography, macroscopy, and frozen section: whıch is better for predicting deep myometrial invasıon in endometrial cancer?

    by Cem Yagmur Ozdemir, Elcin Uzmez Telli, Tufan Oge, Omer Tarik Yalcin

    The aim of this study was to compare the power of preoperative transvaginal ultrasonography, intraoperative macroscopic examination, and frozen section for predicting deep myometrial invasion in endometrial cancer.


  • Open Access

    Comparison of Laparoscopy and Laparotomy in Early-Stage Endometrial Cancer: Early Experiences from a Developing Country

    by Yusuf Cakmak, Duygu Kavak Comert, Isik Sozen, Tufan Oge

    After minimally invasive surgery gained popularity in gynecology, laparoscopic operations became widespread among oncologic operations. However, more studies evaluating experiences of oncologic surgeons during the learning period of laparoscopy are needed. To compare the surgical outcomes and perioperative complications of laparoscopic surgery and laparotomy in the treatment of early-stage endometrioid endometrial cancer patients, we retrospectively investigated patients who underwent surgery due to endometrial cancer at our institution between 2014 and 2018. Early-stage (stage I) endometrioid endometrial cancer patients were included in the study. Operative times, length of hospital stay, extracted pelvic lymph nodes, perioperative complications, and blood loss were compared. A total of 128 patients were treated for stage I endometrial cancer during the study period. Sixty-two patients (48.4) underwent laparoscopic surgery, and 66 (51.6) patients underwent laparotomy. Median operation time and pelvic lymph node count in the laparotomy and laparoscopy groups did not demonstrate statistically significant differences. However, the length of hospital stay, estimated blood loss, and perioperative complication rate were lower in the laparoscopic surgery group. Laparoscopic surgery in early-stage endometrial cancer may be performed with less blood loss, shorter duration of hospital stays, and similar lymph node counts compared to laparotomic surgery.


  • Open Access

    Is Tumor-Free Distance an Independent Prognostic Factor for Early-Stage Endometrioid Endometrial Cancer?

    by Tufan Oge, Duygu Kavak Comert, Yusuf Cakmak, Deniz Arık

    There are many studies assessing the importance of myometrial invasion using a cut-off limit as 50% of myometrial invasion for endometrial cancer, and there are a limited number of studies evaluating tumor-free distance to the serosa. To evaluate the prognostic performance of tumor-free distance and percentage of myometrial invasion in patients with stage IB endometrioid endometrial cancer, we retrospectively evaluated 133 patients diagnosed and treated as stage IB endometrioid endometrial cancer. Tumor-free distance was assessed, and recurrence and recurrence-free survival were analyzed. Nine patients had recurrent disease (6.8%). Recurrence-free survival was 200 months. Two patients died because of malignancy. In the Cox regression model according to tumor-free distance, depth of invasion, and percentage of myometrial invasion, it was seen that none of these parameters were significant to predict the recurrence (p>0.05). In conclusion, tumor-free distance is not an independent prognostic factor for patients with stage IB endometrioid endometrial cancer.


  • Open Access

    Evaluation of clinicopathologic features of patients diagnosed with atypical glandular cells on cervical cytology

    by Yusuf Çakmak, Duygu Kavak Cömert, Tufan Oge, Özgür Aydın Tosun, Işık Sözen

    In our study we aimed to evaluate the clinicopathologic features of patients diagnosed with atyipcal glandular cells on cervical cytology. The records of 9375 patients who were examined in the gynecology outpatient clinic between 2010 and 2018 and underwent cervicovaginal smear were retrospectively reviewed. Seventy-three (0.8%) patients were diagnosed as atypical glandular cells. Colposcopic examination, cervical biopsy, endocervical and endometrial curettage were performed in patients diagnosed with atypical glandular cells. Age, gravida, parity, systemic diseases and clinicopathological features of the patients were examined and recorded Cervical and endometrial abnormal histological findings were detected in 26 (35.6%) of 73 patients with atypical glandular cells. Of these 26 patients, 14 (19.1%) had cervical intraepithelial lesions, 3 (4.1%) had endometrial hyperplasia and 9 (12.3%) had invasive cancer. Five (6.8%) of the 9 patients with the diagnosis of invasive cancer had adenocarcinoma (endocervical and endometrial), in 3 (4.1%) patients cervical squamous carcinoma, and in 1 patient. endocervical lymphoma was observed.The majority of cancers detected in our study were in the age group of 50 years and older. Invasive cancer is seen in 12.3% of the patients diagnosed with atypical glandular cells, and most of these patients are 50 years or older. Therefore patients diagnosed with atypical glandular cell in cervicovaginal smear should be carefully evaluated with all clinical features.


  • Assessment of serum and follicular fluid total oxidant and total antioxidant levels in In Vitro Fertilization (IVF) cases

    by Emel Ozturk, Tufan Oge, Yunus Aydi̇n, Ozben Isi̇klar, Hikmet Hassa

    Objective: To assess the effects of serum and follicular fluid total oxidant (TOC) levels, total antioxidant capacity (TAC), and oxidative stress index (OSI) on oocyte maturation, fertilization, embryogenesis, and clinical pregnancy outcomes in In Vitro Fertilization (IVF) cycles of infertile patients.Materials and Methods: One hundred patients having infertility and underwent ART enrolled the study group and blood samples were collected on gonadotropin starting, oocyte pick-up (OPU) and embryo transfer (ET) days. Additionally, follicular fluid specimen obtained during OPU was collected. TOC, TAC levels and OSI in serum samples and follicular fluid specimens between clinically pregnant and non-pregnant patients were compared.Results: No significant difference was noted between clinically pregnant and nonpregnant patients in terms of the woman's age, duration of infertility, ovarian reserve or number of transferred embryos. There was also no significant difference in TAC, TOC and OSI levels in serum samples obtained during three phases of treatment cycle (basal gonadotropin starting day, OPU day and ET day) and in follicular fluid samples. Conclusion: TAC, TOC and OSI seem to be ineffective to predict clinical pregnancy as an outcome in patients who underwent ART.


  • Süre içerisinde total laparaskopik histerektomi deneyimi

    by Metin Şentürk, Tufan Öge

    Objective: To evaluate single surgerion experience of total laparscopic hyserectomy within a time period. Materials and methods: This retrospective type study included 81 cases of total laparoscopic hysterectomy performed during January and December 2016 due to benign. The first 6 months and the last month were examined in 2 groups. Analysis of the data was done using t test. Results: The highest hysterectomy indications of 81 patients included in the study were endometrial hyperplasia. There were no significant differences in age, parity, BMI, duration of hospital stay, and blood loss between the first 6 months and the last month. When the operation periods of total laparoscopic hysterectomies were compared between the first 6 months and the last 6 months by a single surgeon, it was observed that the operations performed in the last 6 months decreased significantly in duration(p<0,05). Conclusion: The operation time significant decrease after a certain learning curve

  • Open Access

    Does size matter? Retrospective analysis of large gynecologic tumors

    by Tufan Öge, Emel Öztürk, Ömer T. Yalçın

    To evaluate the characteristics of patients who underwent surgery due to the presence of a large pelvic-abdominal mass over a 5-year period in a university clinic. Among 3476 gynecologic operations, intraoperative findings were evaluated retrospectively. Uterine and/or adnexal masses smaller than 20 cm were excluded to refine "large" tumors and 74 patients with large tumors were enrolled in the study group. Demographic characteristics, intraoperative findings, and results of histopathologic examinations were recorded. Moreover, preoperative and intraoperative findings were compared among tumors with adnexal origin according to their final histopathologic results. The mean age of the patients was 46 years. The most common symptom was abdominal pain, as recorded in 38 (51.4%) patients. Among all patients, 31 (41.9%) had coexisting illness and 13 (17.6%) had a history of surgery. The mean tumor diameter was 25.9±8.6 cm (20-60) and 60 (78.9%) tumors were of adnexal origin. The ratios of malignancy for large adnexal and uterine tumors were 34.4% and 12.5%, respectively. When the large adnexal tumors were re-evaluated, the mean cancer antigen (CA) 125 level was significantly higher, and ascites was more frequently detected in malignant tumors (p<0.01) then in benign and borderline tumors. Benign and borderline tumors are more common among large abdominopelvic masses, although the presence of ascites and elevated CA 125 may present malignancy in large gynecologic tumors. Further studies with larger sample sizes are needed to define the characteristics of large tumors and their malignant potentials.


  • Open Access

    Factors associated with survival after relapse in patients with low-risk endometrial cancer treated with surgery alone

    by Nazli Topfedaisi Ozkan, Mehmet Mutlu Meydanlı, Mustafa Erkan Sarı, Fuat Demirkiran, Ilker Kahramanoglu, Tugan Bese, Macit Arvas, Hanifi Şahin, Ali Haberal, Husnu Celik, et al.

    Topfedaisi Ozkan N, et al. J Gynecol Oncol. 2017 Mar;28(5):e65. https://doi.org/10.3802/jgo.2017.28.e65